Hamon Center Therapeutic Oncology - Minna Lab

Medicine & Life Sciences

1. Lung Neoplasms 100%
2. Non-Small Cell Lung Carcinoma 86%
3. Neoplasms 50%
4. Cell Line 41%
5. Genes 33%
6. Small Cell Lung Carcinoma 29%
7. Lung 27%
8. Epithelial Cells 21%
9. Adenocarcinoma of Lung 20%
10. Oncogenes 18%
11. Mutation 18%
12. Gene Expression 17%
13. Tumor Suppressor Genes 15%
14. Epithelial-Mesenchymal Transition 15%
15. ErbB Receptors 15%
16. Methylation 15%
17. Breast Neoplasms 14%
18. Growth 14%
19. Heterografts 13%
20. Carcinogenesis 12%
21. Genome 12%
22. Proteins 12%
23. Apoptosis 11%
24. Therapeutics 11%
25. DNA Mismatch Repair 10%
26. Survival 10%
27. Biomarkers 10%
28. Phenotype 10%
29. Transcriptome 9%
30. DNA Methylation 9%
31. Datasets 8%
32. Epigenomics 8%
33. DNA 8%
34. Microsatellite Instability 8%
35. Adenocarcinoma 7%
36. Poly (ADP-Ribose) Polymerase-1 7%
37. Transcription Factors 7%
38. Tumor Cell Line 7%
39. Alleles 7%
40. Small Interfering RNA 6%
41. alpha-2'-deoxythioguanosine 6%
42. Squamous Cell Carcinoma 6%
43. Messenger RNA 6%
44. Pharmaceutical Preparations 6%
45. Erlotinib Hydrochloride 6%
46. Pancreatic Neoplasms 6%
47. Chromosomes 6%
48. Carcinoma 6%
49. Transgenic Mice 6%
50. Microsatellite Repeats 6%
51. Cell Cycle 6%
52. Radiation 6%
53. Loss of Heterozygosity 6%
54. Notch1 Receptor 5%
55. Cell Survival 5%
56. Proteomics 5%
57. In Vitro Techniques 5%
58. Cytoplasmic and Nuclear Receptors 5%
59. Microarray Analysis 5%
60. Protein-Tyrosine Kinases 5%
61. Genomics 5%
62. Phosphotransferases 5%
63. Neoplasm Metastasis 5%
64. Drug Therapy 5%
65. Single Nucleotide Polymorphism 5%
66. pyrimidine 5%
67. Neuroendocrine Tumors 5%
68. Gefitinib 5%
69. Oligonucleotide Array Sequence Analysis 5%
70. Nicotinic Receptors 5%
71. Cell Movement 5%
72. Cell Proliferation 5%
73. Human Chromosomes 5%
74. RNA 5%
75. Ionizing Radiation 5%
76. Neuroendocrine Carcinoma 5%